Source: International Congress 2014 – Predictors
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ostrovskyy, I. Savelikhina, O. Varunkiv, M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine). Effect of roflumilast on morphological changes in mucous membrane of bronchi in patients with severe chronic obstructive pulmonary disease. Eur Respir J 2014; 44: Suppl. 58, 3618

Member's Comments

No comment yet.

Related content which might interest you: Peculiarities of intracardiac hemodynamics in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Clinical presentations Year: 2014 Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD: points to ponder Year: 2014 LATE-BREAKING ABSTRACT: Evaluation of symptoms and risk on stable chronic obstructive pulmonary disease patients with radiographic bronchiectasis Source: International Congress 2014 – Predictors Year: 2014 Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 Nutritional status in chronic obstructive pulmonary disease Source: International Congress 2014 – Comorbidities Year: 2014 Assessment of treatment efficiency in patients with chronic obstructive pulmonary disease combined with gastroesophageal reflux disease during treatment with melatonin Source: International Congress 2014 – Clinical presentations Year: 2014 Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD exacerbations Year: 2014 Effects of pulmonary rehabilitation on exacerbation number and severity in people with chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Features of the bronchial mucosa in heavy smokers with and without chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease Source: International Congress 2014 – Markers Year: 2014 Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Vascular endothelial dysfunction in chronic obstructive pulmonary disease: Comparison with bronchial asthma, and controls Source: International Congress 2016 – Systemic biomarkers Year: 2016 Clinical relevance of airway remodelling in airway diseases Source: Eur Respir J 2007; 30: 134-155 Year: 2007 Peripheral neuropathy in chronic obstructive pulmonary disease Source: International Congress 2014 – Comorbidities Year: 2014 Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016